Novel method for inhibiting toxic and side effects of DNA toxic chemotherapeutic drugs and application

The invention relates to a novel method for reducing toxic and side effects of chemotherapeutic drugs caused by reactive oxygen species (ROS) by supplementing (injecting or taking) 5-phosphoribose (R5P) after a patient is treated by chemotherapeutic drugs. The novel method has the advantages that af...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ZHOU SA, ZHANG YUJIE, JIN LIJUN, MA WENJIAN, MA NING, ZHANG TENGYUE, LI XINYU, MU JIAKANG, DING CHUNYANG
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ZHOU SA
ZHANG YUJIE
JIN LIJUN
MA WENJIAN
MA NING
ZHANG TENGYUE
LI XINYU
MU JIAKANG
DING CHUNYANG
description The invention relates to a novel method for reducing toxic and side effects of chemotherapeutic drugs caused by reactive oxygen species (ROS) by supplementing (injecting or taking) 5-phosphoribose (R5P) after a patient is treated by chemotherapeutic drugs. The novel method has the advantages that after the chemotherapeutic drugs such as psoralen are used for inducing DNA damage, the ROS level is continuously increased, if R5P is added during cell culture, ROS production is remarkably inhibited, and the DNA repair process is basically not affected or even improved. Meanwhile, the cell volume isnot increased any more (the number of mitochondria is reduced). DNA damage induced ROS is a by-product of substance and energy metabolism through metabolic pathways such as PPP, and activation of thePPP metabolic pathways is to meet the requirement of repairing specific DNA damage. Although the psoralen is mainly used as a model in the description of the invention, R5P-based drug combination canbe universally applied to
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN112451532A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN112451532A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN112451532A3</originalsourceid><addsrcrecordid>eNqNizEOwjAQBN1QIOAPxwMonJAHRAFE5Yo-MvY5PinxWfEF8XwQygOoVpqZ3apg-IUjTCiRPQSegVKkJwmlAYTf5MAmD4U8AoaATgpwgItpV-siTiwRZ5txkS_w8zKU38nmPJKzQpz2ahPsWPCw7k4db9dHdz9h5h5Ltg4TSt8Zratzo5u6aut_mg8zUz8y</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Novel method for inhibiting toxic and side effects of DNA toxic chemotherapeutic drugs and application</title><source>esp@cenet</source><creator>ZHOU SA ; ZHANG YUJIE ; JIN LIJUN ; MA WENJIAN ; MA NING ; ZHANG TENGYUE ; LI XINYU ; MU JIAKANG ; DING CHUNYANG</creator><creatorcontrib>ZHOU SA ; ZHANG YUJIE ; JIN LIJUN ; MA WENJIAN ; MA NING ; ZHANG TENGYUE ; LI XINYU ; MU JIAKANG ; DING CHUNYANG</creatorcontrib><description>The invention relates to a novel method for reducing toxic and side effects of chemotherapeutic drugs caused by reactive oxygen species (ROS) by supplementing (injecting or taking) 5-phosphoribose (R5P) after a patient is treated by chemotherapeutic drugs. The novel method has the advantages that after the chemotherapeutic drugs such as psoralen are used for inducing DNA damage, the ROS level is continuously increased, if R5P is added during cell culture, ROS production is remarkably inhibited, and the DNA repair process is basically not affected or even improved. Meanwhile, the cell volume isnot increased any more (the number of mitochondria is reduced). DNA damage induced ROS is a by-product of substance and energy metabolism through metabolic pathways such as PPP, and activation of thePPP metabolic pathways is to meet the requirement of repairing specific DNA damage. Although the psoralen is mainly used as a model in the description of the invention, R5P-based drug combination canbe universally applied to</description><language>chi ; eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210309&amp;DB=EPODOC&amp;CC=CN&amp;NR=112451532A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210309&amp;DB=EPODOC&amp;CC=CN&amp;NR=112451532A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZHOU SA</creatorcontrib><creatorcontrib>ZHANG YUJIE</creatorcontrib><creatorcontrib>JIN LIJUN</creatorcontrib><creatorcontrib>MA WENJIAN</creatorcontrib><creatorcontrib>MA NING</creatorcontrib><creatorcontrib>ZHANG TENGYUE</creatorcontrib><creatorcontrib>LI XINYU</creatorcontrib><creatorcontrib>MU JIAKANG</creatorcontrib><creatorcontrib>DING CHUNYANG</creatorcontrib><title>Novel method for inhibiting toxic and side effects of DNA toxic chemotherapeutic drugs and application</title><description>The invention relates to a novel method for reducing toxic and side effects of chemotherapeutic drugs caused by reactive oxygen species (ROS) by supplementing (injecting or taking) 5-phosphoribose (R5P) after a patient is treated by chemotherapeutic drugs. The novel method has the advantages that after the chemotherapeutic drugs such as psoralen are used for inducing DNA damage, the ROS level is continuously increased, if R5P is added during cell culture, ROS production is remarkably inhibited, and the DNA repair process is basically not affected or even improved. Meanwhile, the cell volume isnot increased any more (the number of mitochondria is reduced). DNA damage induced ROS is a by-product of substance and energy metabolism through metabolic pathways such as PPP, and activation of thePPP metabolic pathways is to meet the requirement of repairing specific DNA damage. Although the psoralen is mainly used as a model in the description of the invention, R5P-based drug combination canbe universally applied to</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNizEOwjAQBN1QIOAPxwMonJAHRAFE5Yo-MvY5PinxWfEF8XwQygOoVpqZ3apg-IUjTCiRPQSegVKkJwmlAYTf5MAmD4U8AoaATgpwgItpV-siTiwRZ5txkS_w8zKU38nmPJKzQpz2ahPsWPCw7k4db9dHdz9h5h5Ltg4TSt8Zratzo5u6aut_mg8zUz8y</recordid><startdate>20210309</startdate><enddate>20210309</enddate><creator>ZHOU SA</creator><creator>ZHANG YUJIE</creator><creator>JIN LIJUN</creator><creator>MA WENJIAN</creator><creator>MA NING</creator><creator>ZHANG TENGYUE</creator><creator>LI XINYU</creator><creator>MU JIAKANG</creator><creator>DING CHUNYANG</creator><scope>EVB</scope></search><sort><creationdate>20210309</creationdate><title>Novel method for inhibiting toxic and side effects of DNA toxic chemotherapeutic drugs and application</title><author>ZHOU SA ; ZHANG YUJIE ; JIN LIJUN ; MA WENJIAN ; MA NING ; ZHANG TENGYUE ; LI XINYU ; MU JIAKANG ; DING CHUNYANG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN112451532A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2021</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>ZHOU SA</creatorcontrib><creatorcontrib>ZHANG YUJIE</creatorcontrib><creatorcontrib>JIN LIJUN</creatorcontrib><creatorcontrib>MA WENJIAN</creatorcontrib><creatorcontrib>MA NING</creatorcontrib><creatorcontrib>ZHANG TENGYUE</creatorcontrib><creatorcontrib>LI XINYU</creatorcontrib><creatorcontrib>MU JIAKANG</creatorcontrib><creatorcontrib>DING CHUNYANG</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZHOU SA</au><au>ZHANG YUJIE</au><au>JIN LIJUN</au><au>MA WENJIAN</au><au>MA NING</au><au>ZHANG TENGYUE</au><au>LI XINYU</au><au>MU JIAKANG</au><au>DING CHUNYANG</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Novel method for inhibiting toxic and side effects of DNA toxic chemotherapeutic drugs and application</title><date>2021-03-09</date><risdate>2021</risdate><abstract>The invention relates to a novel method for reducing toxic and side effects of chemotherapeutic drugs caused by reactive oxygen species (ROS) by supplementing (injecting or taking) 5-phosphoribose (R5P) after a patient is treated by chemotherapeutic drugs. The novel method has the advantages that after the chemotherapeutic drugs such as psoralen are used for inducing DNA damage, the ROS level is continuously increased, if R5P is added during cell culture, ROS production is remarkably inhibited, and the DNA repair process is basically not affected or even improved. Meanwhile, the cell volume isnot increased any more (the number of mitochondria is reduced). DNA damage induced ROS is a by-product of substance and energy metabolism through metabolic pathways such as PPP, and activation of thePPP metabolic pathways is to meet the requirement of repairing specific DNA damage. Although the psoralen is mainly used as a model in the description of the invention, R5P-based drug combination canbe universally applied to</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN112451532A
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
title Novel method for inhibiting toxic and side effects of DNA toxic chemotherapeutic drugs and application
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T01%3A34%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZHOU%20SA&rft.date=2021-03-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN112451532A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true